Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-31
2006-10-31
Wilson, James O. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S352000, C514S353000, C514S357000, C546S296000, C546S297000, C546S300000, C546S301000
Reexamination Certificate
active
07129246
ABSTRACT:
The invention provides compounds of general formula (I) in which m, A, R1and Ar have the meanings defined in the specification; a process for, and intermediates used in, their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
REFERENCES:
patent: 3464998 (1969-09-01), Krimmel
patent: 3471491 (1969-10-01), Venkatachala et al.
patent: 4751292 (1988-06-01), Fox
patent: 650919 (1964-07-01), None
patent: 1943404 (1970-12-01), None
patent: 0002065 (1979-05-01), None
patent: 0867436 (1998-09-01), None
patent: 90/10622 (1990-09-01), None
patent: WO 95/04720 (1995-02-01), None
patent: WO 99/29660 (1999-06-01), None
patent: WO 99/29661 (1999-06-01), None
patent: WO 00/61569 (2000-10-01), None
patent: WO 01/94338 (2001-12-01), None
patent: WO 03/080579 (2003-10-01), None
Costakis et al., “Synthesis of Some Adamantane Derivatives of 2-Aminobenzothiazoles”,Journal of Medicinal Chemistry14(12):1222-1223 (1971).
Ho et al., “Synthesis of a Peptidomimetic Tricyclic Tetrahydrobenzo[ij] quinoline as a VLA-4 Antagonist”,J. Org. Chem. 65:6743-6748, p. 6745, scheme 5, (27) (2000).
STN International, File REGISTRY, see RN 405068-97-5, 405070-41-9, 405076-22-4, Apr. 14, 2002.
STN International, File REGISTRY, see RN 445032-09-7, Aug. 30, 2002.
STN International, File CHEMCATS, Accession No. 2001:48444, May 14, 2001, NS18552, 2-Quinolinecarboxamide, N-(tricycle[3.3.1.13,7]dec-1-ylmethyl), CAS Registry No. 313688-07-2.
STN International, File REGISTRY, see RN 401622-10-4, Mar. 24, 2002.
Alcaraz Lilian
Johnson Timothy
Stocks Michael
AstraZeneca AB
Fish & Richardson P.C.
Robinson Binta
Wilson James O.
LandOfFree
N-adamantlmethyl derivatives and intermediates as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-adamantlmethyl derivatives and intermediates as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-adamantlmethyl derivatives and intermediates as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3637436